ArticleInflammopharmacology2020

Pretreatment with interleukin 35-engineered mesenchymal stem cells protected against lipopolysaccharide-induced acute lung injury via pulmonary inflammation suppression.

Xiaoning Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.